The $3,000 Dog Vaccine That Big Pharma Craves - Energy & Capital
Takeda just dropped $1.7 billion on a deal with Iambic Therapeutics a month ago, and Merck developed something called KERMT, which is an AI model that ...
Read the original at Energy & Capital ↗
- Topics
- HealthcareEnergy & Environment
- Tracked via
- “An AI Model that”